Pailinrut Chinwangso

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

Anh Duc Dang, Vũ Đình Thiểm, Ha Hai Vu et al. · Vaccine · 2022 · 39 citations · Full text

Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial

Punnee Pitisuttithum, Kulkanya Chokephaibulkit, Chukiat Sirivichayakul et al. · The Lancet Infectious Diseases · 2018 · 38 citations

Vaccinology, Vaccination, Cross-protection +8

A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial

Sirintip Sricharoenchai, Chukiat Sirivichayakul, Kulkanya Chokephaibulkit et al. · The Lancet Infectious Diseases · 2017 · 34 citations

Vaccinology, Vaccine Safety, Vaccination +10

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

Chukiat Sirivichayakul, Pornthep Chanthavanich, Kriengsak Limkittikul et al. · Human Vaccines & Immunotherapeutics · 2016 · 27 citations · Full text

Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

Géraldine Blanchard‐Rohner, Olga Chatzis, Pailinrut Chinwangso et al. · Clinical Infectious Diseases · 2018 · 22 citations · Full text